European Drug Safety & AI 2026

24–25 Feb 2026 | Barcelona, Spain

Wednesday, 25 February 2026 | 11:00 - 11:50

PANEL DISCUSSION: DEMYSTIFYING AI IN PHARMACOVIGILANCE

Location:Gloria B, C, D
  • Common Assumption: Human-in-the-loop automatically solves risk 

  • Common Assumption: Validation is something you do once, then move on 

  • Common Assumption: If it is accurate, it is compliant 

  • Common Assumption: More data automatically leads to better AI 

  • The hype vs reality in applications of AI in PV risk management

4 speakers

  • Chief Customer Officer

    Synapmed

  • Global Head Medical Safety

    Organon

  • Global Safety Director, EU/ EEA QPPV

    Indivior

  • Head of Global Pharmacovigilance, QPPVEU

    Worwag Pharma

Location image

Session location Gloria B, C, D